Biotech Values

[mcbio]

Dew, I don't know if you are an institutional or private investor in MNTA, but help me rationalize how you can be a fan of MNTA at a 52 week low, aka:

finance.yahoo.com/q/bc?s=MNTA+Basic+Chart&t=1y

What am I missing? Inefficient market theory at its best?

If you think that MNTA/BAX will succeed in developing interchangeable biologics of any of the large biologics they are likely targeting, I don't think it's that hard at all to envision MNTA shares likely being cheap at current valuation. This development is still likely a few years away, though, so I'm on the sidelines for now.